相关实验视频

Updated: Sep 17, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

长非编码RNA在前列腺癌中的新兴作用和临床前景

Rajarethinam Kumar¹, Saradhadevi Muthukrishnan²

¹Translational Genomics Research Laboratory, Department of Biochemistry, Bharathiar University, Coimbatore, Tamil Nadu, India.

Medical oncology (Northwood, London, England)

|June 27, 2025

概括

长非编码RNAs (lncRNAs) 是前列腺癌 (PCa) 发展和进展的关键调节者. 了解 lncRNA 网络为改善 PCa 患者的诊断和个性化治疗提供了新的希望.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

前列腺癌 (PCa) 仍然是一个重大的全球健康挑战,具有侵略性和耐治疗性形式构成重大障碍.
长非编码RNAs (lncRNAs) 越来越被认为是PCa中的关键调节者,影响细胞周期,基因表达和转移.
失调的lncRNAs影响关键的细胞过程,并驱动PCa的进展,包括调节雄激素受体 (AR) 信号.

研究的目的:

在PCa中审查和整合 lncRNA介导的监管网络的最新进展.
突出 lncRNAs 在表观遗传,转录后调节和关键信号通路中的作用.
强调 lncRNAs 作为个性化医学的预测生物标志物和治疗点的临床应用.

主要方法:

关于PCa中 lncRNAs 的最新研究的综合文献综述.
在表观遗传和转录后调节中分析lncRNA功能.
整合关于lncRNA参与PCa信号通路和临床相关性的数据.

主要成果:

lncRNAs在PCa的发病过程中起着关键的作用,影响瘤的生长,进展和转移.
lncRNAs作为竞争性内源RNAs (ceRNAs) 作用,影响微RNA标和基因表达.
lncRNAs参与调节AR信号,这是PCa的一个关键途径.

结论:

lncRNA研究为改善早期PCa诊断和开发有效的个性化疗法提供了重大前景.
了解复杂的lncRNA网络对于克服患者异质性等挑战至关重要.
将lncRNA研究转化为临床应用需要对其治疗潜力的持续调查.

关键词:

生物标志物生物标志物长长的非编码RNAs.预测指标预测指标前列腺癌是什么意思前列腺癌是什么意思治疗目标治疗目标

更多相关视频

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Types of RNA

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...